Clinique Du Parc

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute lymphoblastic leukaemia1 trial
• Bladder cancer1 trial
• Multiple myeloma1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Assistance Publique - Hôpitaux de Paris1 trial
• Centre Hospitalier De Versailles1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Not yet recruiting

  A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL

  2024-516570-30-00· Phase 2· Centre Hospitalier De Versailles· Source

• Recruiting

  Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone

  NCT06561854· Phase 3· Assistance Publique - Hôpitaux de Paris· Source

• Active, not recruiting

  A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guérin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy

  NCT04640623· Phase 2· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute lymphoblastic leukaemia1 recruiting
• Multiple myeloma1 recruiting